FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for GLATOPA (glatiramer acetate) from Sandoz Inc., making it an approved generic treatment for relapsing forms of multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLATOPA (GLATIRAMER ACETATE)

Snippet

SUPPL AP for GLATOPA (GLATIRAMER ACETATE)